mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors

被引：2
|
作者：
Yekeduz, Emre [1 ,2 ]
Ayasun, Ruveyda [2 ,3 ]
Koksoy, Elif Berna [1 ,2 ]
Utkan, Gungor [1 ,2 ]
Urun, Yuksel [1 ,2 ]
Akbulut, Hakan [1 ,2 ]
机构：
[1] Ankara Univ, Dept Med Oncol, Ankara, Turkey
[2] Ankara Univ, Canc Res Inst, Ankara, Turkey
[3] Hacettepe Univ, Dept Med Oncol, Canc Inst, Ankara, Turkey
来源：
FUTURE VIROLOGY | 2021年 / 16卷 / 09期
关键词：
cancer; COVID-19; immunotherapy; mRNA; SARS-CoV-2; vaccine; INFLUENZA VACCINATION; SAFETY; IMMUNOGENICITY;
D O I：
10.2217/fvl-2021-0166
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：583 / 585
页数：3
相关论文
共 50 条
  • [1] The impact of COVID-19 mRNA vaccines on immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors
    Guo, Mengni
    Ahmed, Zohaib
    Phuong Nguyen
    Zaidi, Kashaf
    Itzkowitz, Raphael
    Chong, Esther G.
    Castillo, Dani Ran
    Huynh Le Cao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Chen, Yu-Wei
    Tucker, Matthew D.
    Beckermann, Kathryn E.
    Iams, Wade T.
    Rini, Brian I.
    Johnson, Douglas B.
    EUROPEAN JOURNAL OF CANCER, 2021, 155 : 291 - 293
  • [3] Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors
    Klebanov, Nikolai
    Pahalyants, Vartan
    Murphy, William S.
    Theodosakis, Nicholas
    Zubiri, Leyre
    Klevens, R. Monina
    Kwatra, Shawn G.
    Lilly, Evelyn
    Reynolds, Kerry L.
    Semenov, Yevgeniy R.
    ONCOLOGIST, 2021, 26 (05): : E898 - E901
  • [4] IMPACT OF COVID-19 ON CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Tyan, Kevin
    Bui, Ai-Tram
    Giobbie-Hurder, Anita
    Klein, Isaac
    Manos, Michael
    Zubiri, Leyre
    Reynolds, Kerry
    Grover, Shilpa
    Weinhouse, Gerald
    Ott, Patrick
    LeBoeuf, Nicole
    Rahma, Osama
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A296 - A298
  • [5] COVID-19 vaccines in patients with urothelial cancers receiving immune checkpoint inhibitors.
    Gilbert, Danielle
    Hu, Junxiao
    Lam, Elaine T.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [6] COVID-19 vaccines in patients with solid tumor cancers receiving immune checkpoint inhibitors
    Gilbert, Danielle
    Hu, Junxiao
    Lam, Elaine T.
    CANCER RESEARCH, 2023, 83 (07)
  • [7] The impact of COVID-19 infection on immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors
    Guo, Mengni
    Liu, Jieying
    Ahmed, Zohaib
    Yu, James
    Miao, Ruoyu
    Guan, Jian
    Pour, Mohammad Ali Esmaeil
    Khayyat, Azadeh
    Grove, Angela
    Manoucheri, Manoucher
    Socinski, Mark A.
    Mekhail, Tarek
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Immune checkpoint inhibitors in cancer patients with COVID-19
    Pan, Yun
    Tan, Jiaxiong
    Li, Jinzhong
    Li, Taoyuan
    Li, Jieying
    Cao, Yang
    Yang, Liu
    Lin, Xunge
    Li, Minran
    Liang, Xujing
    OPEN LIFE SCIENCES, 2023, 18 (01):
  • [9] COVID-19 VACCINATION IN PATIENTS WITH RENAL CANCER OR MELANOMA RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Hwang, Joyce
    Dzimitrowicz, Hannah
    Shah, Riddhishkumar
    Ashcraft, Kathleen
    George, Daniel
    Salama, April
    Zhang, Tian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A655 - A655
  • [10] COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review
    Ruiz, Juan I.
    Lopez-Olivo, Maria A.
    Geng, Yimin
    Suarez-Almazor, Maria E.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2023, 6 (02) : 103 - 110
12345